This paper is in the following e-collection/theme issue:

mHealth in a Clinical Setting (756) Patient-Reported Outcome Measures (PROMs) (377) Innovations and Technology in Cancer Care (549) Electronic Health Records (1348) Participatory Medicine & E-Patients (889) Electronic/Mobile Data Capture, Internet-based Survey & Research Methodology (1007) Breast Cancer (302) mHealth for Data Collection and Research (1217) Mobile Apps for Cancer Care and Cancer Prevention and Screening (272)

Published on in Vol 14 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/67514, first published .
Evaluating the Feasibility of an Electronic Patient-Reported Outcomes Platform Integrating Electronic Health Records and a Mobile Messaging App in Breast Cancer Radiotherapy: Retrospective Cross-Sectional Study

Evaluating the Feasibility of an Electronic Patient-Reported Outcomes Platform Integrating Electronic Health Records and a Mobile Messaging App in Breast Cancer Radiotherapy: Retrospective Cross-Sectional Study

Evaluating the Feasibility of an Electronic Patient-Reported Outcomes Platform Integrating Electronic Health Records and a Mobile Messaging App in Breast Cancer Radiotherapy: Retrospective Cross-Sectional Study

Authors of this article:

Jong Yun Baek1 Author Orcid Image ;   Haeyoung Kim1 Author Orcid Image ;   Won Kyung Cho1 Author Orcid Image ;   Nalee Kim1 Author Orcid Image ;   Tae Hoon Lee1 Author Orcid Image ;   Won Chul Cha2, 3 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Jong Yun Baek   1 * , MD ;   Haeyoung Kim   1 * , MD, PhD ;   Won Kyung Cho   1 , MD ;   Nalee Kim   1 , MD, PhD ;   Tae Hoon Lee   1 , MD, PhD ;   Won Chul Cha   2, 3 , MD, PhD

1 Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

2 Department of Digital Health, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Republic of Korea

3 Data Innovation Center, Samsung Medical Center, Seoul, Republic of Korea, Seoul, Republic of Korea

*these authors contributed equally

Corresponding Author:

  • Haeyoung Kim, MD, PhD
  • Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine
  • 81 Irwon-ro, Gangnam-gu, Seoul
  • Seoul 06351
  • Republic of Korea
  • Phone: 82 2-3410-2612
  • Fax: 82 2-3410-2619
  • Email: haeyoung0131.kim@samsung.com